Molina Healthcare, Inc (NYSE:MOH) Given Average Rating of “Hold” by Analysts

Molina Healthcare, Inc (NYSE:MOH) has been given a consensus rating of “Hold” by the sixteen brokerages that are currently covering the stock, MarketBeat reports. Two investment analysts have rated the stock with a sell recommendation, eleven have assigned a hold recommendation and three have assigned a buy recommendation to the company. The average 1-year target price among brokerages that have issued a report on the stock in the last year is $178.5333.

A number of research firms have recently commented on MOH. Mizuho lowered their price target on Molina Healthcare from $220.00 to $180.00 and set an “outperform” rating for the company in a report on Thursday, March 12th. Zacks Research raised Molina Healthcare from a “strong sell” rating to a “hold” rating in a report on Monday, April 20th. Bank of America raised Molina Healthcare from an “underperform” rating to a “buy” rating and set a $250.00 price target for the company in a report on Wednesday, April 29th. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and set a $129.00 price target on shares of Molina Healthcare in a report on Friday, April 24th. Finally, Sanford C. Bernstein reaffirmed an “outperform” rating on shares of Molina Healthcare in a report on Friday, March 13th.

Insider Transactions at Molina Healthcare

In other news, CAO Maurice Hebert sold 600 shares of Molina Healthcare stock in a transaction dated Thursday, May 14th. The stock was sold at an average price of $191.55, for a total transaction of $114,930.00. Following the sale, the chief accounting officer directly owned 12,815 shares of the company’s stock, valued at approximately $2,454,713.25. This trade represents a 4.47% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Jeff D. Barlow sold 17,811 shares of Molina Healthcare stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $186.12, for a total value of $3,314,983.32. Following the sale, the insider directly owned 67,175 shares in the company, valued at $12,502,611. The trade was a 20.96% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 1.44% of the company’s stock.

Institutional Trading of Molina Healthcare

Hedge funds have recently made changes to their positions in the company. CenterBook Partners LP grew its position in shares of Molina Healthcare by 359.7% in the 3rd quarter. CenterBook Partners LP now owns 20,409 shares of the company’s stock valued at $3,905,000 after buying an additional 15,969 shares during the last quarter. BNP Paribas Financial Markets grew its position in shares of Molina Healthcare by 63.0% in the 4th quarter. BNP Paribas Financial Markets now owns 439,371 shares of the company’s stock valued at $76,248,000 after buying an additional 169,739 shares during the last quarter. Fiera Capital Corp grew its position in shares of Molina Healthcare by 68.8% in the 3rd quarter. Fiera Capital Corp now owns 241,581 shares of the company’s stock valued at $46,229,000 after buying an additional 98,431 shares during the last quarter. DDD Partners LLC bought a new stake in shares of Molina Healthcare in the 3rd quarter valued at about $1,743,000. Finally, Timber Creek Capital Management LLC bought a new stake in shares of Molina Healthcare in the 3rd quarter valued at about $4,467,000. 98.50% of the stock is owned by institutional investors and hedge funds.

Molina Healthcare Price Performance

Shares of NYSE MOH opened at $184.46 on Thursday. The company has a debt-to-equity ratio of 0.97, a current ratio of 1.63 and a quick ratio of 1.63. Molina Healthcare has a fifty-two week low of $121.06 and a fifty-two week high of $311.52. The stock has a market capitalization of $9.61 billion, a PE ratio of 54.57 and a beta of 0.80. The business has a fifty day moving average price of $166.36 and a two-hundred day moving average price of $161.80.

Molina Healthcare (NYSE:MOH) last posted its quarterly earnings results on Wednesday, April 22nd. The company reported $2.35 EPS for the quarter, topping analysts’ consensus estimates of $1.57 by $0.78. Molina Healthcare had a return on equity of 8.76% and a net margin of 0.42%.The company had revenue of $10.80 billion during the quarter, compared to analysts’ expectations of $10.91 billion. During the same quarter in the previous year, the firm earned $6.08 EPS. Molina Healthcare’s revenue was down 3.1% on a year-over-year basis. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. As a group, equities analysts predict that Molina Healthcare will post 5.23 earnings per share for the current fiscal year.

About Molina Healthcare

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.